Gestop

Quick links to important sections

Gestop

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gestop

Property Description
Active ingredients Ethinyl Estradiol, Gestodene
Form Oral tablet
Pharmacological class Combined Hormonal Contraceptive (CHC)
Common use Prevention of pregnancy (Birth control)
Origin Synthetic

What Type of Medicine is Gestop?

Gestop is an oral preparation classified as a Combined Hormonal Contraceptive (CHC), which works systemically to prevent pregnancy. This medicine is a fixed-dose combination product, consistently delivering two types of synthetic hormones in each active tablet. It falls within the pharmacological class of Estrogen and Progestin Combinations. This class of combination pills is designed for the oral route of administration and relies on the complementary actions of its hormonal agents. Combined hormonal contraceptives are recognized as a highly effective method of reversible birth control. This indicates that the drug provides a reliable, established means of preventing conception when used by women of child-bearing age.

Composition and Origin: Ethinyl Estradiol and Gestodene

The active ingredients in Gestop are Ethinyl Estradiol, a synthetic estrogen, and Gestodene, a synthetic progestin. Both compounds are chemically manufactured and are not derived from natural sources, defining the preparation's origin as synthetic. Gestodene belongs to the group of third-generation progestins. This indicates that the medicine utilizes a newer, often lower-dose progestin to achieve its effects. The combination of Ethinyl Estradiol and Gestodene constitutes the hormonal core of the product, which is physically presented as a solid oral tablet preparation.

Primary Purpose of Gestop

The primary and general purpose of Gestop is the effective prevention of pregnancy. This objective is realized through the drug’s ability to manipulate the female reproductive cycle via hormonal action. The combination acts by signaling the body that it is in a state equivalent to pregnancy, which suppresses the processes necessary for conception. This contraceptive action is clinically recognized for providing high efficacy in preventing conception. This action fulfills the fundamental user need for a daily, non-surgical method of birth control.

Regulatory References

  1. NIH Oral Contraceptive Pills Information
  2. Ethinylestradiol/Gestodene Public Assessment Report (PAR)

What side effects are possible with Gestop?

Possible Side Effects and Safety Information

The official safety profile for Gestop (Ethinyl Estradiol and Gestodene) is structured around categories established by government health agencies to communicate potential risks. The most significant concern, documented in regulatory warnings, is the increased risk of thromboembolic disorders (blood clots), which are classified as serious adverse reactions.


Adverse Reactions by Classification

Classification Examples of Officially Listed Effects
Serious Adverse Reactions Venous Thromboembolism (VTE), Arterial Thromboembolism (ATE, including stroke and heart attack), and Benign or Malignant Liver Tumors.
Common Adverse Reactions Nausea, vomiting, headache, breast pain or tenderness, and bleeding irregularities like spotting or breakthrough bleeding.
System-Organ Classes Effects are frequently reported in the Vascular, Hepatobiliary, Nervous System, and Reproductive systems.

Time-Related and Population Safety Notes

The risk of blood clots is often highest during the first year of use or upon re-starting the medication after a break of four weeks or more, as stated in regulatory documents. Use is formally restricted or contraindicated in individuals with specific pre-existing vascular risk factors, such as severe hypertension, a history of VTE/ATE, or a history of migraine with focal neurological symptoms.

Special population considerations noted in official labeling include an increased cardiovascular risk for smokers over age 35 and guidance against use in the immediate postpartum period due to elevated thromboembolic risk.

Overdose and Emergency Response

Gestop Overdose and When to Seek Help

Overdose with Gestop, a Combined Hormonal Contraceptive (CHC), is generally associated with a low acute toxicity profile and is not likely to be life-threatening, according to official regulatory documentation. The manifestations that occur after ingesting a quantity above the prescribed dose are primarily transient hormonal effects, which are not considered severe outcomes.

Documented Manifestations and Management

Category Official Regulatory Statement
Common Symptoms Nausea, vomiting, and delayed withdrawal bleeding (vaginal bleeding).
Antidote Status No specific antidote is known or documented.
Required Management Treatment is mandated as symptomatic and supportive treatment.

When to Seek Urgent Medical Help

If an overdose is known or suspected, the official guidance requires that the patient seek immediate medical attention or contact a poison control center right away. The clinical response focuses on supportive care and the monitoring of vital signs. This management approach is necessary because, as stated in regulatory materials, no specific treatment exists to reverse the hormonal effects. Furthermore, official labeling notes that pediatric data are not available regarding overdose scenarios for this product.

Therapeutic Uses of Gestop

What Gestop Treats: Main Uses and Benefits

Gestop, a Combined Hormonal Contraceptive, is primarily used for managing the prevention of pregnancy but also provides established therapeutic benefits for managing various menstrual and hormonal symptoms. These types of oral contraceptives are also applied in situations requiring symptomatic support for other conditions.

Primary Indication: Effective Contraception and Symptom Control

Gestop's primary purpose is providing an established daily method for the prevention of pregnancy in women of child-bearing age. This systematic approach may assist in the prevention of unintended conception, and it supports the management of symptoms associated with conditions like Polycystic Ovary Syndrome (PCOS) and is commonly used to help with hormonally-driven acne. It may assist with the symptomatic relief of severe pain and cramping (dysmenorrhea) and excessive menstrual blood loss (menorrhagia), and supports the development of a predictable schedule for periods.

This medication is generally used when patients seek appropriate conception prevention alongside the management of cyclical symptoms that interfere with daily comfort.


Quick Fact: Management of Heavy Periods Gestop may assist with the symptomatic relief of excessive menstrual blood loss, which helps ease the overall symptom burden associated with menorrhagia.

Regulatory References

  1. NIH National Library of Medicine

Eligibility and Restrictions for Use

Who Can and Cannot Use Gestop?

Gestop, a Combined Hormonal Contraceptive (CHC), is officially indicated for use by females of reproductive age for the prevention of pregnancy. Regulatory agencies strictly define populations who are eligible for use and those who are absolutely prohibited.

Contraindications: Populations Who Must Not Use Gestop

The most severe restrictions relate to the risk of blood clots (thromboembolism) and hormone-sensitive conditions. Gestop is contraindicated if you have or have a history of:

  • Arterial or Venous Thrombotic Diseases: Such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, or coronary artery disease.
  • Hormone-Sensitive Cancers: Including current or history of breast cancer or other estrogen-dependent tumors.
  • Severe Liver Disease or Tumors: Until liver function has returned to normal.
  • Severe Uncontrolled Hypertension or vascular disease.
  • Smoking and are over age 35.
  • Known or Suspected Pregnancy.
  • Migraine with aura or focal neurological symptoms.

Other Official Restrictions

  • Lactation: Use is not recommended for nursing mothers as it may affect milk production.
  • Postpartum Period: Use should not begin until four weeks after delivery due to a heightened risk of blood clots.
  • Surgery: The medicine must be discontinued at least four weeks before and two weeks after major surgery or prolonged immobilization.

What should I know about interactions with other medicines?

The official regulatory profile for Gestop is defined by pharmacokinetic changes affecting the hormonal components, Ethinyl Estradiol and Gestodene.

Contraindicated Combinations

Co-administration with specific Hepatitis C drug combinations, including regimens containing ombitasvir / paritaprevir / ritonavir (with or without dasabuvir), is strictly contraindicated due to the risk of liver enzyme elevations.

Pharmacokinetic Interactions

Interactions are primarily based on effects on hepatic microsomal enzymes.

  • Enzyme Inducers increase the clearance of the hormones, potentially causing a significant reduction in contraceptive efficacy. This category includes anticonvulsants such as Phenytoin and Carbamazepine, the antibiotic Rifampicin, and the herbal product St John's wort.
  • Enzyme Inhibitors (e.g., certain Azole Antifungals and Macrolides) may reduce hormonal clearance, leading to increased plasma concentrations.

Interaction Restrictions

  • Timing Rule: For short-term co-administration with an enzyme-inducing drug, the continued use of a non-hormonal barrier method is required for 28 days after discontinuation of the inducer.
  • Gestop as Perpetrator: The combination itself markedly increases the plasma concentrations of co-administered drugs like Tizanidine by inhibiting its metabolism via the CYP1A2 pathway.
  • Food/Substance: Grapefruit or Grapefruit juice is officially noted to potentially alter the absorption of the medicine, and co-administration is restricted in patients with severe hepatic disease due to impaired clearance.

Mechanism of Action

How Gestop Works

Gestop (Gestodene) is a synthetic progestin that acts as a ligand for the intracellular progesterone receptor (PR). Upon binding, the Gestop-PR complex translocates into the cell nucleus, where it modulates gene transcription by interacting with progesterone response elements (PREs) on DNA. Its primary physiological effect is the alteration of the hypothalamic-pituitary-ovarian (HPO) axis.

By mimicking the negative feedback signals of endogenous progesterone, Gestop inhibits the pulsatile secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus. This central suppression reduces the pituitary gland’s output of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). The resulting absence of the preovulatory LH surge is the key molecular event that modulates ovarian function.

Peripherally, Gestop also modifies tissue structure. It induces a rapid thickening of the cervical mucus, restricting the passage of spermatozoa. Concurrently, it causes specific changes in the endometrium, leading to decidualization and structural thinning. These actions are strictly confined to modifying physiological processes via receptor agonism and HPO axis activity.

Dosage and Administration Information

Gestop, an oral preparation combining Ethinyl Estradiol and Gestodene, is administered exclusively by the oral route as a daily tablet. The usage is defined by a 28-day cyclic pattern, consisting of 21 consecutive days of active hormone tablets followed by 7 days of hormone-free or placebo tablets. This standardized regimen establishes the pattern for continuous, long-term administration.

Official Administration Guidelines

Feature Guideline
Dosing Schedule One tablet taken daily in a 28-day cyclic pattern (21 active / 7 hormone-free).
Daily Timing Tablet must be administered at approximately the same time every day to maintain consistent systemic hormone levels.
Starting Method Regimen initiation uses either the "Day 1 Start" (first day of menses) or the "Sunday Start" method.
Missed Dose Guidelines detail procedural steps for missed active tablets, with required actions varying based on the time elapsed and the specific week of the cycle.
Special Conditions Concurrently, backup nonhormonal barrier contraception is advised for the first seven days of the initial cycle. Gastrointestinal upset (vomiting or severe diarrhea) occurring shortly after intake necessitates taking a replacement tablet.

No specific dose adjustments are specified for patients with renal or hepatic impairment; guidelines restrict use based on the underlying condition rather than recommending a dose modification. The entire protocol focuses exclusively on the correct intake timing, sequence, and continuity of the tablet phases.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Gestop (Ethinyl Estradiol/Gestodene)


Evidence for Use in Pregnancy Prevention

Research examining the use of Gestop for contraception involves large-scale, intermediate-term clinical trials that were non-comparative or were designed to compare characteristics against other combined oral contraceptives (COCs). The primary outcome measured was the rate of pregnancy, tracked using metrics such as the Pearl Index. The recorded rates of pregnancy reflect the rates noted under the conditions of the trial, taking into account adherence patterns. Evidence concerning long-term patterns over many years of continuous use is not fully established within controlled trials, instead relying more on large, ongoing observational studies that monitor the population over extended periods.


Evidence for Menstrual Symptom Management

Research has also explored the evaluation of combined oral contraceptives like Gestop in individuals with conditions characterized by fluctuating or episodic manifestations related to the menstrual cycle. This includes studies relevant in trials assessing short-term symptom patterns, such as excessive menstrual blood loss (menorrhagia) and severe menstrual pain (dysmenorrhea). In these research scenarios, trials and systematic reviews report patterns showing how symptoms evolved in the observed populations during the study period.


Evidence for Managing Acne Vulgaris

Gestop was evaluated in randomized controlled trials (RCTs) examining its use in conditions associated with inflammatory or irritative states, specifically hormonally-driven acne vulgaris. Research populations included women with mild to moderate acne. Studies monitored outcomes linked to inflammatory lesion counts and the overall severity of acne symptoms. Findings indicate observed data patterns related to the changes in lesion counts in the populations studied. Comparative evidence is often limited, and long-term effects concerning the durability of observed skin changes after the regimen is stopped are not fully established.


Areas of Research Uncertainty and Gaps

Follow-up durations were limited in many controlled trials, so long-term outcomes are not well characterized. Comparative evidence is lacking in some areas, as many studies compare one active hormonal regimen to another rather than to a non-treatment control. The evidence quality varies across studies, and findings describing group patterns do not determine whether an individual will respond similarly.

Key Studies & References Oral Contraceptive Pills (StatPearls/NIH Bookshelf) - General Overview of COC Efficacy and Indications

Frequently Asked Questions (FAQ)

Common questions about Gestop (FAQ)


Q: What happens if someone stops taking Gestop suddenly?

Stopping the tablets removes the medicine's contraceptive effect, which means pregnancy may occur. Official warnings indicate that for certain suspected medical conditions, such as a blood clot or stroke, stopping the tablets is typically required immediately.


Q: How quickly can a person expect to feel the effects of Gestop?

Official prescribing information indicates that the contraceptive effect may not be fully established until after the first seven consecutive days of taking the active tablets. For this reason, official guidance notes that a backup non-hormonal contraception method is typically used during that initial seven-day period.


Q: What does it mean if Gestop does not seem to be working?

For its primary purpose, any suspicion of pregnancy requires medical evaluation. For secondary benefits, such as managing symptoms like acne, continued or worsening symptoms are often subject to professional evaluation. It is common for irregular bleeding, such as spotting, to occur in the first few months of use, and this is generally not considered a sign that the medicine is ineffective.


Q: Is it safe to consume alcohol while using Gestop?

The official product information does not list alcohol as a specific contraindication or a major drug interaction requiring a blanket warning. However, alcohol and this medication are both processed by the liver. Specific guidance regarding consumption levels is typically obtained from a healthcare professional.


Q: Is it normal to experience non-specific symptoms like tiredness when first starting Gestop?

The official safety profile lists several common adverse reactions, including nausea, headache, and breast tenderness. The regulatory documentation does not specifically address whether these feelings are considered 'normal' or transient during the initial adjustment phase.


Q: What is the typical timeframe for when the full benefits of Gestop are usually noticed?

For contraceptive efficacy, the medicine reaches its intended effect after seven consecutive days of active tablet intake. For other potential benefits, such as managing acne or menstrual symptoms, research evidence indicates that observed effects are typically assessed over several cycles, which is usually three to six months.


Q: Can Gestop be taken with or without food?

Official administration guidance states that the tablets can generally be taken either with or without food. Official administration guidance emphasizes that the tablet is administered at approximately the same time every day to maintain consistent hormone levels.


Q: What is the best way to handle a missed dose of Gestop?

The procedure for handling a missed dose varies based on how many tablets were missed and the specific week of the cycle this occurred. The general guidance for one missed active tablet indicates that the tablet is taken as soon as possible, followed by the next tablet at the regular time, which may involve taking two tablets in one day.


Q: Does Gestop have a 'loading' phase?

The term 'loading phase' is not used in the official regulatory prescribing information for this medicine. The regimen is designed as a standard 28-day cyclic pattern. However, official guidance does advise using backup contraception for the first seven days, which is a method of initial precaution.


Q: Can I take Gestop with over-the-counter pain relievers like ibuprofen or acetaminophen?

Official drug labels provide detailed warnings for interactions with strong liver enzyme-altering drugs, such as certain antibiotics and herbal supplements. These labels do not typically list common over-the-counter pain relievers as requiring specific warnings or contraindications.


Q: Is Gestop a medication that is taken long-term or short-term?

Gestop is indicated for oral contraception, which official documents describe as a method of continuous, long-term administration. This long-term use is defined by the standardized 28-day cyclic pattern.


Q: Does Gestop cause weight gain?

Official regulatory documents list weight gain among the possible common adverse reactions that have been reported in clinical trial data for Combined Hormonal Contraceptives.


Q: Are there any known long-term effects of taking Gestop for many years?

Official research overviews indicate that controlled clinical trials have limited follow-up durations, meaning long-term outcomes over many years are not fully established by those trials. Long-term safety data relies more heavily on ongoing observational studies.


Q: Are there any ingredients in Gestop that are common allergens?

Official product labels list both the active ingredients (hormones) and all inactive ingredients, or excipients. Individuals with known allergies to any listed component often check this information against their personal allergies.


Q: Can Gestop interact with common prescription medications for high blood pressure or cholesterol?

Regulatory documentation explicitly contraindicates the use of Gestop in patients with severe uncontrolled hypertension or specific vascular disease. The medication may also affect the metabolism of certain other co-administered drugs, and a health professional typically reviews all current prescriptions.


Q: How does taking Gestop affect the ability to drive or operate machinery?

Official product information generally states that Combined Hormonal Contraceptives are not known to affect the ability to drive or operate heavy machinery. This is because these medicines are not typically associated with side effects like sedation or impaired cognitive judgment.


Q: Do generics of Gestop work the same as the brand name?

To receive regulatory approval, generic versions must demonstrate pharmaceutical equivalence (same active ingredients, dosage form, and route of administration) and bioequivalence. Bioequivalence means the generic product has a similar rate and extent of absorption in the body compared to the brand name reference product.


Q: Are there ongoing clinical trials related to new uses for Gestop?

Current, ongoing trials for the active ingredients in Gestop would not be listed in the official drug label itself. However, information about new uses or studies can be searched in public, government-run research databases, such as ClinicalTrials.gov.


Q: Why do some patients report feeling worse when they first start Gestop?

Official regulatory safety information notes that certain adverse effects, such as bleeding irregularities or nausea, are often reported more frequently during the first few months of use. This is often related to the body's initial adjustment period to the new hormonal levels.


Q: Does Gestop interact with birth control pills?

Gestop is a birth control pill, classified as a Combined Hormonal Contraceptive (CHC). Taking it simultaneously with another hormonal contraceptive is contraindicated by official regulatory warnings because it exposes the user to a higher level of hormones than intended, which may increase the risk of adverse reactions.


Q: What are the signs of an allergic reaction to Gestop that warrant immediate attention?

Official patient safety warnings detail that signs of a severe allergic reaction (hypersensitivity) require immediate medical attention. These symptoms can include hives, significant swelling of the face, lips, tongue, or throat, or difficulty breathing.


Q: Is Gestop a controlled substance?

According to the US Controlled Substances Act and similar international legislation, Combined Hormonal Contraceptives like Gestop are not classified as controlled substances.


Q: How should Gestop tablets or capsules be taken?

The preparation is manufactured as an oral tablet and is intended to be swallowed whole with liquid. Official guidance indicates that the tablets should not be crushed or chewed.

How should Gestop be stored and disposed of?

How to Store and Dispose of Gestop

Gestop tablets must be stored according to regulatory requirements to maintain the stability of the active hormonal ingredients. The medication must be kept at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Storage conditions require protection from excessive heat, moisture, and freezing.

Packaging and Safety

It is mandatory to store Gestop in its original container and ensure the container is tightly closed to protect the tablets from light and humidity. For safety, the product must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Gestop should be disposed of via an authorized drug take-back program or mail-back service. If these options are unavailable, the FDA recommends mixing the medicine with an undesirable substance, placing it in a sealed container, and discarding it in the household trash. The tablets must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gestop found in:

A-Z Index: